| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| B Group, Inc. | 13% | $7,560,000 | 3,000,000 | The B Group, Inc. | 18 Aug 2025 | |||
| Anson Funds Management LP | 9.3% | +33% | $4,044,537 | +$1,073,303 | 1,604,975 | +36% | Anson Funds Management LP | 30 Jun 2025 |
As of 30 Sep 2025, 24 institutional investors reported holding 3,956,630 shares of NRX Pharmaceuticals, Inc. - Common Stock, $0.001 par value (NRXP). This represents 17% of the company’s total 23,771,791 outstanding shares.
The largest institutional shareholders of NRX Pharmaceuticals, Inc. - Common Stock, $0.001 par value (NRXP) together control 17% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Anson Funds Management LP | 8.5% | 2,025,104 | +26% | 0.74% | $6,682,843 |
| VANGUARD GROUP INC | 2.3% | 534,956 | +18% | 0% | $1,765,355 |
| AdvisorShares Investments LLC | 1.4% | 342,136 | +30% | 0.18% | $1,129,049 |
| MARSHALL WACE, LLP | 0.8% | 189,136 | +467% | 0% | $624,150 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.78% | 185,862 | +7.9% | 0% | $613,455 |
| UBS Group AG | 0.64% | 152,848 | +26% | 0% | $504,399 |
| RENAISSANCE TECHNOLOGIES LLC | 0.54% | 128,175 | 0% | $422,978 | |
| STATE STREET CORP | 0.32% | 76,284 | +49% | 0% | $251,737 |
| JANE STREET GROUP, LLC | 0.31% | 73,399 | 0% | $242,217 | |
| BlackRock, Inc. | 0.28% | 65,412 | +1.6% | 0% | $215,860 |
| TWO SIGMA INVESTMENTS, LP | 0.22% | 52,332 | +66% | 0% | $172,696 |
| Chicago Partners Investment Group LLC | 0.18% | 41,994 | 0% | $125,982 | |
| NORTHERN TRUST CORP | 0.12% | 28,601 | 0% | 0% | $94,383 |
| One Wealth Management Investment & Advisory Services, LLC | 0.12% | 27,991 | +86% | 0.11% | $92,370 |
| Ethos Financial Group, LLC | 0.05% | 11,900 | 0% | $39,270 | |
| MORGAN STANLEY | 0.05% | 11,080 | +152% | 0% | $36,564 |
| BANK OF AMERICA CORP /DE/ | 0.01% | 3,400 | -3.5% | 0% | $11,220 |
| SBI Securities Co., Ltd. | 0.01% | 2,500 | -26% | 0% | $8,250 |
| WELLS FARGO & COMPANY/MN | 0.01% | 2,000 | 0% | 0% | $6,600 |
| OSAIC HOLDINGS, INC. | 0% | 1,090 | +1111% | 0% | $2,528 |
| Tower Research Capital LLC (TRC) | 0% | 324 | -72% | 0% | $1,069 |
| Carolina Wealth Advisors, LLC | 0% | 50 | 0% | 0% | $165 |
| JPMORGAN CHASE & CO | 0% | 34 | 0% | 0% | $112 |
| Larson Financial Group LLC | 0% | 22 | 0% | 0% | $73 |
| SIMPLEX TRADING, LLC | 0% | 0 | -100% | $0 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 3,956,630 | $13,043,325 | +$3,167,782 | $3.30 | 24 |
| 2025 Q2 | 2,994,368 | $9,761,438 | +$2,410,568 | $3.26 | 25 |
| 2025 Q1 | 2,260,524 | $4,602,262 | +$2,464,506 | $2.05 | 22 |
| 2024 Q4 | 1,048,552 | $2,306,649 | +$754,289 | $2.20 | 24 |
| 2024 Q3 | 714,327 | $1,207,232 | +$328,213 | $1.69 | 20 |
| 2024 Q2 | 510,346 | $1,261,065 | +$1,261,065 | $2.44 | 20 |